Patents by Inventor Brian C. THOMAS

Brian C. THOMAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260193623
    Abstract: The present disclosure provides systems and methods for transposing a cargo nucleotide sequence to a target nucleic acid sequence. These systems and methods can comprise a nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence is configured to interact with a retrotransposase, and the retrotransposase, wherein the retrotransposase is configured to transpose the cargo nucleotide sequence to the target nucleic acid sequence. The systems and methods can also involve use of functional fragments of retrotransposases.
    Type: Application
    Filed: December 8, 2023
    Publication date: July 9, 2026
    Applicant: Metagenomi, Inc.
    Inventors: Brian C. THOMAS, Lisa ALEXANDER, Christopher BROWN, Cindy CASTELLE, Daniela S.A. GOLTSMAN, Sarah LAPERRIERE, Morayma TEMOCHE-DIAZ, Anu THOMAS, Mary Kaitlyn CHIU (née TSAI)
  • Publication number: 20260185061
    Abstract: The disclosure relates to gene editing systems comprising serine recombinases and methods of using such serine recombinases for integration of nucleic acid sequences. More specifically, the disclosure relates to sequence-defined serine recombinases having attachment sites such as a bacterial genomic recombination sequence (attB). Methods are also provided for recombinant pro-duction of said recombinases.
    Type: Application
    Filed: November 6, 2023
    Publication date: July 2, 2026
    Inventors: Brian C. THOMAS, Christopher BROWN, Cindy CASTELLE, Gregory J. COST, Daniela S.A. GOLTSMAN, Khak Khak KHAYI, Sarah LAPERRIERE, Jason LIU, Soungsothira TOCH
  • Publication number: 20260146263
    Abstract: The disclosure relates generally to gene editing systems comprising reverse transcriptases and fusion proteins of reverse transcriptases with nickases or nucleases, methods of making such reverse transcriptases and fusion proteins, and methods of using such reverse transcriptases and fusion proteins for site directed genome editing in cells.
    Type: Application
    Filed: October 18, 2023
    Publication date: May 28, 2026
    Inventors: Brian C. THOMAS, Christopher BROWN, Daniela S.A. GOLTSMAN, Sourab KULKARNI, Sarah LAPERRIERE, Leanna MONTELEONE, Morayma TEMOCHE-DIAZ, Anu THOMAS
  • Publication number: 20260132392
    Abstract: The disclosure relates generally to gene editing systems comprising reverse transcriptases and fusion proteins of reverse transcriptases with nickases or nucleases, methods of making such reverse transcriptases and fusion proteins, and methods of using such reverse transcriptases and fusion proteins for site directed genome editing in cells.
    Type: Application
    Filed: October 18, 2023
    Publication date: May 14, 2026
    Inventors: Brian C. Thomas, Lisa Alexander, Ketaki Belsare, Christopher Brown, Cindy Castelle, Daniela S.A. Goltsman, Sourab Kulkarni, Sarah Laperriere, Leanna Monteleone, Maria Jose Soto Contreras, Morayma Temoche-Diaz, Anu Thomas, Mary Kaitlyn Chui, Rebecca Lamothe
  • Publication number: 20260115320
    Abstract: Described herein are methods, compositions, and systems derived from uncultivated microorganisms useful supplementing liver enzyme deficiencies.
    Type: Application
    Filed: December 23, 2025
    Publication date: April 30, 2026
    Inventors: Brian C. Thomas, Alan Brooks
  • Publication number: 20260115319
    Abstract: Described herein are methods, compositions, and systems derived from uncultivated microorganisms useful supplementing liver enzyme deficiencies.
    Type: Application
    Filed: December 23, 2025
    Publication date: April 30, 2026
    Inventors: Brian C. Thomas, Alan Brooks
  • Publication number: 20260115321
    Abstract: Described herein are methods, compositions, and systems derived from uncultivated microorganisms useful supplementing liver enzyme deficiencies.
    Type: Application
    Filed: December 23, 2025
    Publication date: April 30, 2026
    Inventors: Brian C. Thomas, Alan Brooks
  • Publication number: 20260078412
    Abstract: The present disclosure provides for endonuclease enzymes as well as methods of using such enzymes or variants thereof.
    Type: Application
    Filed: July 29, 2025
    Publication date: March 19, 2026
    Inventors: Brian C. THOMAS, Christopher BROWN, Audra DEVOTO, Cristina BUTTERFIELD, Lisa ALEXANDER, Daniela S.A. GOLTSMAN, Rebecca LAMOTHE, Isabel NOCEDAL
  • Patent number: 12533424
    Abstract: Described herein are methods, compositions, and systems derived from uncultivated microorganisms useful supplementing liver enzyme deficiencies.
    Type: Grant
    Filed: November 25, 2024
    Date of Patent: January 27, 2026
    Assignee: Metagenomi, Inc.
    Inventors: Brian C. Thomas, Alan Brooks
  • Patent number: 12503710
    Abstract: The present disclosure provides for endonuclease enzymes having distinguishing domain features, as well as methods of using such enzymes or variants thereof.
    Type: Grant
    Filed: May 2, 2024
    Date of Patent: December 23, 2025
    Assignee: Metagenomi, Inc.
    Inventors: Brian C. Thomas, Jyun-Liang Lin, Alan Brooks, Cristina Butterfield, Christopher Brown, Cindy Castelle, Morayma Temoche-Diaz, Benjamin Freeman, Christine Romano, Rebecca Lamothe
  • Patent number: 12410449
    Abstract: The present disclosure provides for endonuclease enzymes as well as methods of using such enzymes or variants thereof.
    Type: Grant
    Filed: May 21, 2024
    Date of Patent: September 9, 2025
    Assignee: Metagenomi, Inc.
    Inventors: Brian C. Thomas, Christopher Brown, Cristina Butterfield, Lisa Alexander, Daniela S. A. Goltsman, Rebecca Lamothe, Isabel Nocedal
  • Publication number: 20250197891
    Abstract: The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site in a target nucleic acid. These systems and methods may comprise a double-stranded nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence is configured to interact with a recombinase complex, an effector complex comprising an effector and at least one engineered guide polynucleotide configured to hybridize to the target nucleic acid, and the recombinase complex wherein the recombinase complex is configured to recruit the cargo nucleotide to the target nucleic acid site.
    Type: Application
    Filed: February 23, 2023
    Publication date: June 19, 2025
    Inventors: Brian C. Thomas, Christopher Brown, Daniela S.A. Goltsman, Cristina Noel Butterfield, Lisa Alexander, Jason Liu, Gregory J. Cost, Christine Romano
  • Publication number: 20250179530
    Abstract: The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site in a target nucleic acid. These systems and methods may comprise a double-stranded nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence is configured to interact with a recombinase or transposase complex, an effector complex comprising an effector and at least one engineered guide polynucleotide configured to hybridize to the target nucleic acid, and the recombinase or transposase complex wherein said recombinase or transposase complex is configured to recruit the cargo nucleotide to the target nucleic acid site.
    Type: Application
    Filed: February 23, 2023
    Publication date: June 5, 2025
    Inventors: Brian C. Thomas, Christopher Brown, Daniela S.A. Goltsman, Cristina Noel Butterfield, Lisa Alexander, Jason Liu, Gregory J. Cost, Khak Khak Khayi
  • Publication number: 20250179452
    Abstract: The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site in a target nucleic acid. These systems and methods may comprise a double-stranded nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence is configured to interact with a recombinase or transposase complex, an effector complex comprising an effector and at least one engineered guide polynucleotide configured to hybridize to the target nucleic acid, and the recombinase or transposase complex wherein said recombinase or transposase complex is configured to recruit the cargo nucleotide to the target nucleic acid site.
    Type: Application
    Filed: February 23, 2023
    Publication date: June 5, 2025
    Inventors: Brian C. Thomas, Christopher Brown, Daniela S.A. Goltsman, Cristina Noel Butterfield, Lisa Alexander, Jason Liu, Gregory J. Cost, Christine Romano
  • Publication number: 20250179484
    Abstract: The present disclosure provides systems and methods for transposing a cargo nucleotide sequence into a target nucleic acid site. These systems and methods may comprise a double-stranded nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence is configured to interact with a recombinase complex, an effector complex comprising an effector and at least one engineered guide polynucleotide configured to hybridize to the target nucleic acid site, and the recombinase complex wherein said recombinase complex is configured to recruit the cargo nucleotide to the target nucleic acid site.
    Type: Application
    Filed: February 23, 2023
    Publication date: June 5, 2025
    Inventors: Brian C. Thomas, Christopher Brown, Daniela S.A. Goltsman, Cristina Noel Butterfield, Lisa Alexander, Jason Liu, Gregory J. Cost, Khak Khak Khayi
  • Publication number: 20250161491
    Abstract: Described herein are methods, compositions, and systems derived from uncultivated microorganisms useful supplementing liver enzyme deficiencies.
    Type: Application
    Filed: November 25, 2024
    Publication date: May 22, 2025
    Inventors: Brian C. Thomas, Alan Brooks
  • Patent number: 12286654
    Abstract: The present disclosure provides for endonuclease enzymes having distinguishing domain features, as well as methods of using such enzymes or variants thereof.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: April 29, 2025
    Assignee: Metagenomi, Inc.
    Inventors: Jyun-Liang Lin, Alan Brooks, Cristina Butterfield, Christopher Brown, Cindy Castelle, Brian C. Thomas
  • Publication number: 20250075233
    Abstract: Described herein are methods, compositions, and systems for multiplex editing using Cas enzymes or editing of T-cells or related cells using Cas enzymes.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 6, 2025
    Inventors: Brian C. THOMAS, Christopher BROWN, Audra DEVOTO, Cristina BUTTERFIELD, Lisa ALEXANDER, Daniela S.A. GOLTSMAN, Greg COST, Rebecca LAMOTHE, Diego ESPINOSA
  • Publication number: 20250002886
    Abstract: Disclosed herein are engineered nucleases and nuclease systems, including chimeric nucleases and chimeric nuclease systems. Engineered and chimeric nucleases disclosed herein include nucleic acid guided nuclease. Additionally disclosed herein are methods of generating engineered nucleases and methods of using the same.
    Type: Application
    Filed: September 13, 2024
    Publication date: January 2, 2025
    Inventors: Brian C. Thomas, Alan Brooks, Christopher Brown, Cristina Noel Butterfield, Daniela S.A. Goltsman, Jyun-Liang Lin, Isabel Nocedal, Morayma Temoche-Diaz
  • Publication number: 20250002881
    Abstract: Described herein are methods, compositions, and systems derived from uncultivated microorganisms useful for gene editing.
    Type: Application
    Filed: March 5, 2024
    Publication date: January 2, 2025
    Inventors: Brian C. THOMAS, Christopher BROWN, Cindy CASTELLE, Lisa ALEXANDER, Liliana GONZALEZ-OSORIO, Paula MATHEUS CARNEVALI, Dom CASTANZO